EARNEST Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-111
| Closed | -$38.6K | – | 1069 |
|
2023
Q3 | $38.6K | Hold |
111
| – | – | ﹤0.01% | 393 |
|
2023
Q2 | $39.1K | Hold |
111
| – | – | ﹤0.01% | 373 |
|
2023
Q1 | $35K | Hold |
111
| – | – | ﹤0.01% | 379 |
|
2022
Q4 | $32.1K | Hold |
111
| – | – | ﹤0.01% | 393 |
|
2022
Q3 | $32K | Hold |
111
| – | – | ﹤0.01% | 378 |
|
2022
Q2 | $31K | Hold |
111
| – | – | ﹤0.01% | 389 |
|
2022
Q1 | $29K | Hold |
111
| – | – | ﹤0.01% | 414 |
|
2021
Q4 | $24K | Hold |
111
| – | – | ﹤0.01% | 458 |
|
2021
Q3 | $20K | Hold |
111
| – | – | ﹤0.01% | 488 |
|
2021
Q2 | $22K | Hold |
111
| – | – | ﹤0.01% | 462 |
|
2021
Q1 | $24K | Hold |
111
| – | – | ﹤0.01% | 432 |
|
2020
Q4 | $26K | Hold |
111
| – | – | ﹤0.01% | 401 |
|
2020
Q3 | $30K | Hold |
111
| – | – | ﹤0.01% | 349 |
|
2020
Q2 | $32K | Hold |
111
| – | – | ﹤0.01% | 334 |
|
2020
Q1 | $26K | Hold |
111
| – | – | ﹤0.01% | 354 |
|
2019
Q4 | $24K | Hold |
111
| – | – | ﹤0.01% | 407 |
|
2019
Q3 | $19K | Hold |
111
| – | – | ﹤0.01% | 456 |
|
2019
Q2 | $20K | Hold |
111
| – | – | ﹤0.01% | 449 |
|
2019
Q1 | $20K | Hold |
111
| – | – | ﹤0.01% | 443 |
|
2018
Q4 | $18K | Hold |
111
| – | – | ﹤0.01% | 439 |
|
2018
Q3 | $21K | Hold |
111
| – | – | ﹤0.01% | 428 |
|
2018
Q2 | $19K | Hold |
111
| – | – | ﹤0.01% | 445 |
|
2018
Q1 | $18K | Hold |
111
| – | – | ﹤0.01% | 451 |
|
2017
Q4 | $17K | Buy |
+111
| New | +$17K | ﹤0.01% | 454 |
|
2017
Q1 | – | Sell |
-111
| Closed | -$8K | – | 886 |
|
2016
Q4 | $8K | Buy |
+111
| New | +$8K | ﹤0.01% | 576 |
|